{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:31:08Z","timestamp":1759969868442,"version":"build-2065373602"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.maturitas.2007.10.003","type":"journal-article","created":{"date-parts":[[2008,2,5]],"date-time":"2008-02-05T08:33:19Z","timestamp":1202200399000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating leptin and ghrelin are differentially influenced by estrogen\/progestin therapy and raloxifene"],"prefix":"10.1016","volume":"59","author":[{"given":"Irene V.","family":"Lambrinoudaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Christodoulakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel V.","family":"Economou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia A.","family":"Vlachou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantinos P.","family":"Panoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas P.","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia E.","family":"Kouskouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C.","family":"Creatsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2007.10.003_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0889-8545(02)00011-6","article-title":"Reproductive hormones and cardiovascular disease mechanism of action and clinical implications","volume":"29","author":"Wagner","year":"2002","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.maturitas.2007.10.003_bib2","first-page":"35","article-title":"Cardiovascular disease after menopause: a growing epidemic","volume":"58","author":"Alexander","year":"2006","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-135-1-200107030-00003","article-title":"Postmenopausal hormone use and secondary prevention of coronary events in the nurses\u2019 health study. A prospective, observational study","volume":"135","author":"Grodstein","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2007.10.003_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2007.10.003_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2007.10.003_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.12.004","article-title":"Controversies regarding hormone therapy: Insights from inflammation and hemostasis","volume":"70","author":"Koh","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.maturitas.2007.10.003_bib7","first-page":"85","article-title":"Raloxifene: bone and cardiovascular effects","volume":"28","author":"Francucci","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.maturitas.2007.10.003_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/diabetes.47.6.913","article-title":"Leptin secretion from subcutaneous and visceral adipose tissue in women","volume":"47","author":"Van Harmelen","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.maturitas.2007.10.003_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tem.2005.07.010","article-title":"Central actions of adipocyte hormones","volume":"16","author":"Ahima","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2007.10.003_bib11","first-page":"141","article-title":"Leptin stimulates rat aortic smooth muscle cell proliferation and migration","volume":"47","author":"Oda","year":"2001","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.maturitas.2007.10.003_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","article-title":"Leptin and atherosclerosis","volume":"189","author":"Beltowski","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.maturitas.2007.10.003_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.maturitas.2007.10.003_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/gye.16.6.479.491","article-title":"Effects of sex steroid hormones and menopause on serum leptin concentrations","volume":"16","author":"Di Carlo","year":"2002","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00042192-200007030-00004","article-title":"Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women","volume":"7","author":"Baranowska","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2007.10.003_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/oxfordjournals.aje.a009317","article-title":"Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy","volume":"146","author":"Haffner","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib17","first-page":"3424","article-title":"Effects of gender, body composition, and menopause on plasma concentrations of leptin","volume":"81","author":"Rosenbaum","year":"1996","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.maturitas.2007.10.003_bib19","first-page":"3803","article-title":"Growth hormone secretagogue binding sites in peripheral human tissues","volume":"85","author":"Papotti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.coph.2005.10.006","article-title":"Ghrelin and cardiovascular health","volume":"6","author":"Garcia","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.peptides.2003.12.020","article-title":"Estrogen modulates ghrelin expression in the female rat stomach","volume":"25","author":"Matsubara","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.maturitas.2007.10.003_bib22","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1210\/jc.2004-2016","article-title":"Estrogen replacement therapy increases plasma ghrelin levels","volume":"90","author":"Kellokoski","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib23","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.fertnstert.2006.04.043","article-title":"A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome","volume":"86","author":"Chu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2007.10.003_bib24","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1210\/jc.2006-1225","article-title":"Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating fas and fas ligand expression","volume":"91","author":"Seli","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0272-6386(03)00202-6","article-title":"Soluble Fas: a novel predictor of atherosclerosis in dialysis patients","volume":"41","author":"Troyanov","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.maturitas.2007.10.003_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2006.05.045","article-title":"Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene","volume":"193","author":"Christodoulakos","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.maturitas.2007.10.003_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/hh0901.090975","article-title":"Leptin enhances the calcification of vascular cells: artery wall as a target of leptin","volume":"88","author":"Parhami","year":"2001","journal-title":"Cir Res"},{"key":"10.1016\/j.maturitas.2007.10.003_bib28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1096\/fasebj.13.10.1231","article-title":"Leptin induces oxidative stress in human endothelial cells","volume":"13","author":"Bouloumie","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.maturitas.2007.10.003_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/ajpendo.00125.2005","article-title":"Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signalling complex","volume":"289","author":"Elbatarny","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.0000127960.28627.75","article-title":"Independent association between plasma leptin and C-reactive protein in healthy humans","volume":"109","author":"Shamsuzzaman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2007.10.003_bib31","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.ijo.0801825","article-title":"Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals","volume":"25","author":"van Dielen","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.maturitas.2007.10.003_bib32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.ATV.0000171994.89106.ca","article-title":"Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network","volume":"25","author":"Schiekofer","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/emm.2001.17","article-title":"Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro","volume":"33","author":"Park","year":"2001","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.maturitas.2007.10.003_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.ijo.0801947","article-title":"Modulation by leptin of proliferation and apoptosis in vascular endothelial cells","volume":"26","author":"Artwohl","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.maturitas.2007.10.003_bib35","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10620-006-9244-8","article-title":"In vitro and in vivo protection of stellate cells from apoptosis by leptin","volume":"51","author":"Qamar","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.maturitas.2007.10.003_bib36","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.4049\/jimmunol.176.12.7745","article-title":"Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice","volume":"176","author":"Papathanassoglou","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0065-2776(08)60672-0","article-title":"Fas and Fas ligand: a death factor and its receptor","volume":"57","author":"Nagata","year":"1994","journal-title":"Adv Immunol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1053\/ajkd.2001.29224","article-title":"Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease","volume":"38","author":"Hebert","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.maturitas.2007.10.003_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000250616.26308.d7","article-title":"Increased soluble Fas plasma levels in subjects at high cardiovascular risk. Atorvastatin on Inflammatory Markers (AIM) Study, a Substudy of ACTFAST","volume":"27","author":"Blanco-Colio","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-123-9-199511010-00005","article-title":"Changes in energy balance and body composition at menopause: a controlled longitudinal study","volume":"123","author":"Pohelman","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2007.10.003_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"Stampfer","year":"1991","journal-title":"Prev Med"},{"key":"10.1016\/j.maturitas.2007.10.003_bib42","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/meta.2000.9519","article-title":"Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women","volume":"49","author":"Thomas","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2007.10.003_bib43","first-page":"12","article-title":"Body fat distribution, the menopause transition, and hormone replacement therapy","volume":"26","author":"Tchernof","year":"2000","journal-title":"Diab Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.maturitas.2003.07.001","article-title":"Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women","volume":"48","author":"Lambrinoudaki","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2007.10.003_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5122(00)00166-3","article-title":"The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women","volume":"37","author":"Hadji","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2007.10.003_bib46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2265.1999.00796.x","article-title":"Effects of short-term hormone replacement on serum leptin levels in postmenopausal women","volume":"5","author":"Lavoie","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2265.1999.00813.x","article-title":"Effects of administration of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women","volume":"51","author":"Elbers","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-5122(00)00153-5","article-title":"Plasma leptin levels in obese and non-obese postmenopausal women before and after hormone replacement therapy","volume":"36","author":"Konukoglu","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2007.10.003_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00042192-200007010-00007","article-title":"Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy","volume":"7","author":"Di Carlo","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2007.10.003_bib50","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.GME.0000109313.11228.2B","article-title":"Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy","volume":"11","author":"Di Carlo","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2007.10.003_bib51","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/BF03349162","article-title":"Determinants of serum leptin levels in healthy postmenopausal women","volume":"26","author":"Lambrinoudaki","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.maturitas.2007.10.003_bib52","first-page":"416","article-title":"Circulating leptin doesn not change in postmenopausal women receiving replacement therapy with tibolone","volume":"68","author":"Basurto","year":"2000","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/j.maturitas.2007.10.003_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00404-004-0686-y","article-title":"Does tibolone affect serum leptin levels and body weight in postmenopausal women?","volume":"272","author":"Gol","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.maturitas.2007.10.003_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0301-2115(00)00399-7","article-title":"The influence of tibolone upon serum leptin levels in post-menopausal women","volume":"96","author":"Panidis","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajog.2005.01.023","article-title":"Raloxifene increases serum leptin levels in postmenopausal women: a prospective study","volume":"193","author":"Cakmak","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib56","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.gme.0000227335.27996.d8","article-title":"Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene","volume":"13","author":"Tommaselli","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2007.10.003_bib57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1152\/ajpregu.2001.280.5.R1483","article-title":"Hemodynamic and hormonal effects of human ghrelin in healthy volunteers","volume":"280","author":"Nagaya","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00005344-200206000-00001","article-title":"Vasodilatory effect of ghrelin, an endogenous peptide from the stomach","volume":"39","author":"Okumura","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0704228","article-title":"[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis","volume":"134","author":"Katugampola","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib60","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/sj.bjp.0704815","article-title":"Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1","volume":"136","author":"Wiley","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib61","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.CIR.0000127956.43874.F2","article-title":"Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2007.10.003_bib62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.1.01977","article-title":"Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects","volume":"153","author":"Suematsu","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib63","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.105.553883","article-title":"Ghrelin improves endothelial function in patients with metabolic syndrome","volume":"112","author":"Tesauro","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2007.10.003_bib64","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.arcmed.2006.03.004","article-title":"Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome","volume":"37","author":"Kotani","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1016\/j.maturitas.2007.10.003_bib65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.0300-0664.2001.01456.x","article-title":"Weight loss increases circulating levels of ghrelin in human obesity","volume":"56","author":"Hansen","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.maturitas.2007.10.003_bib66","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Human plasma ghrelin levels after diet-induced weight loss and gastric bypass surgery","volume":"346","author":"Cummings","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2007.10.003_bib67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.maturitas.2007.10.003_bib68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","article-title":"Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion","volume":"87","author":"Shiiya","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib69","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1210\/jc.2002-020776","article-title":"Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels","volume":"87","author":"Pagotto","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF03347020","article-title":"Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.maturitas.2007.10.003_bib71","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1210\/jc.2003-030513","article-title":"Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans","volume":"88","author":"Purnell","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib72","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1210\/jc.2006-0948","article-title":"Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women","volume":"91","author":"Veldhuis","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib73","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"MORE investigators (multiple outcomes of raloxifene evaluation). Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four year results from the MORE trial","volume":"287","author":"Barrett-Connor","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2007.10.003_bib74","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/hq0901.095565","article-title":"Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women","volume":"21","author":"Saitta","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.maturitas.2007.10.003_bib75","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(02)04673-3","article-title":"Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women","volume":"79","author":"Christodoulakos","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2007.10.003_bib76","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1210\/jc.2002-021557","article-title":"Endothelial function and menopause, effects of raloxifene administration","volume":"88","author":"Colacurci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2007.10.003_bib77","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.fertnstert.2004.03.030","article-title":"Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women","volume":"82","author":"Christodoulakos","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2007.10.003_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512207002952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512207002952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:45:28Z","timestamp":1759913128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512207002952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0378512207002952"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2007.10.003","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating leptin and ghrelin are differentially influenced by estrogen\/progestin therapy and raloxifene","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2007.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}